FOLFIRINOX until progression, FOLFIRINOX with maintenance treatment, or sequential treatment with gemcitabine and FOLFIRI.3 for first-line treatment of metastatic pancreatic cancer: A randomized phase II trial (PRODIGE 35-PANOPTIMOX).

叶黄素 医学 吉西他滨 福尔菲里 伊立替康 肿瘤科 内科学 胰腺癌 随机对照试验 无进展生存期 化疗 总体生存率 癌症 结直肠癌
作者
Laétitia Dahan,Jean Marc Phelip,Karine Le Malicot,Nicolas Williet,Jérôme Desrame,Julien Volet,C. Pétorin,David Malka,Christine Rebischung,Thomas Aparicio,Cédric Lecaille,Yves Rinaldi,Anthony Turpin,Anne Bignon,Jean‐Baptiste Bachet,Jean François Seitz,Côme Lepage,Ετιεννε François
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:36 (15_suppl): 4000-4000 被引量:40
标识
DOI:10.1200/jco.2018.36.15_suppl.4000
摘要

4000 Background: Metastatic pancreatic cancer (mPC) still harbors a dismal prognosis (5-year overall survival [OS] <5%). Our previous trial (PRODIGE4-ACCORD11) has demonstrated the superiority of 6-month [m] chemotherapy with FOLFIRINOX over gemcitabine in terms of progression-free survival [PFS] (6.4 vs. 3.3 m; HR: 0.47; 95%CI: 0.37-0.59; p<0.001) and OS (11.1 vs. 6.8 m; HR: 0.57; 95%CI: 0.45-0.73; p<0.001), at the expense of higher toxicity, notably cumulative, often limiting, peripheral neuropathy with oxaliplatin. In this randomized Phase II trial, we aimed to assess an oxaliplatin ‘stop-and-go’ strategy and an alternative sequential strategy in mPC. Methods: Patients (pts) were randomized to receive either 6m FOLFIRINOX (arm A), 4m FOLFIRINOX followed by LV5FU2 maintenance treatment for controlled pts, and treatment reintroduction at disease progression (arm B), or a sequential treatment alternating gemcitabine and FOLFIRI.3 every 2m (arm C). The primary endpoint was to evaluate the 6m-PFS rate (H0: 30%, H1: 45%, Fleming design) in order to select the best therapeutic strategy for a future Phase III clinical trial. Results: Between Jan 2015 and Nov 2016, 273 pts (mean age: 63 years; range: 40-76) were enrolled (A: 91; B: 92; C: 90). The median durations of treatment were 5.1, 6.2, and 4.4 m in A, B, and C respectively. Grade 3/4 neurotoxicity occurred in 10% of pts in arm A and 19% of pts in arm B. Median ratio of oxaliplatin was 83% in A and 92% in B. 6m-PFS rates were 47% in A, 44% in B, and 34% in C. 4m objective response rates were 35% in A, 41% in B, and 17% in C. Median PFS was respectively 6.3, 5.7 and 4.5 m in A, B and C. Median OS was 10.1 in A, 11.2 in B and 7.3 m in C. The median duration of first maintenance therapy in B was 3.3 m (range: 0.03-22.6). Conclusions: Maintenance with LV5FU2 appears to be feasible and effective in patients with mPC controlled after 4m of induction chemotherapy with FOLFIRINOX. Severe neurotoxicity rate was higher in the maintenance therapy arm, likely because of higher cumulative oxaliplatin dose.1Conroy NEJM 2011. Clinical trial information: NCT02352337.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Akim应助暖部采纳,获得10
1秒前
赘婿应助简奥斯汀采纳,获得30
1秒前
MQ发布了新的文献求助10
2秒前
小李李完成签到 ,获得积分10
2秒前
2秒前
MISSIW完成签到,获得积分10
4秒前
清爽老九完成签到,获得积分10
5秒前
superhero完成签到,获得积分10
6秒前
最初呢发布了新的文献求助10
8秒前
lll完成签到,获得积分10
8秒前
10秒前
Jasper应助白茶泡泡球采纳,获得10
11秒前
spenley发布了新的文献求助10
14秒前
14秒前
天真小甜瓜完成签到,获得积分10
16秒前
泥過完成签到 ,获得积分10
17秒前
海心完成签到 ,获得积分10
18秒前
想啊想完成签到,获得积分10
18秒前
英勇含烟应助小远远采纳,获得10
18秒前
19秒前
wad1314完成签到,获得积分10
20秒前
杨凤智完成签到 ,获得积分10
20秒前
20秒前
yanjiusheng完成签到,获得积分10
22秒前
22秒前
24秒前
科研小白完成签到 ,获得积分10
25秒前
香蕉觅云应助Snieno采纳,获得10
26秒前
邹栗完成签到 ,获得积分10
27秒前
27秒前
麻辣厨子发布了新的文献求助10
28秒前
最初呢完成签到,获得积分10
29秒前
30秒前
BELIEVE发布了新的文献求助30
32秒前
科研通AI5应助kellen采纳,获得10
34秒前
潇洒的诗桃应助whichwhy采纳,获得10
34秒前
kai_完成签到,获得积分10
35秒前
shijie805发布了新的文献求助10
35秒前
Snieno完成签到,获得积分10
36秒前
豚豚完成签到,获得积分10
37秒前
高分求助中
Production Logging: Theoretical and Interpretive Elements 2700
Neuromuscular and Electrodiagnostic Medicine Board Review 1000
こんなに痛いのにどうして「なんでもない」と医者にいわれてしまうのでしょうか 510
The First Nuclear Era: The Life and Times of a Technological Fixer 500
Unusual formation of 4-diazo-3-nitriminopyrazoles upon acid nitration of pyrazolo[3,4-d][1,2,3]triazoles 500
岡本唐貴自伝的回想画集 500
Distinct Aggregation Behaviors and Rheological Responses of Two Terminally Functionalized Polyisoprenes with Different Quadruple Hydrogen Bonding Motifs 450
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 物理 生物化学 纳米技术 计算机科学 化学工程 内科学 复合材料 物理化学 电极 遗传学 量子力学 基因 冶金 催化作用
热门帖子
关注 科研通微信公众号,转发送积分 3671635
求助须知:如何正确求助?哪些是违规求助? 3228335
关于积分的说明 9779690
捐赠科研通 2938645
什么是DOI,文献DOI怎么找? 1610206
邀请新用户注册赠送积分活动 760547
科研通“疑难数据库(出版商)”最低求助积分说明 736093